Tweet about the ASRM 2022 Scientific Congress & Expo with #ASRM2022 and join the conversation.
#ASRM2022 can also be used for Instagram!
The theme of the 2022 Scientific Congress of the American Society for Reproductive Medicine is “Genes, Gametes and Genetics.” The scope of reproductive medicine is broad ranging from puberty to menopause, including males and females, while having a focus that is both molecular and macroscopic. The program is balanced between science at the cellular level and innovation of reproductive medicine in using cutting edge information in the clinical care of patients to promote positive outcomes for families. This live program is designed for physicians, nurses, andrology and embryology laboratory personnel, genetic counselors, social workers, practice, and laboratory managers, as well as specialists in mental health, law, and ethics to advance exemplary medical care and disseminate innovative research. These goals will be addressed by a wide array of educational activities. The CME/CE portion of the Scientific Congress will include plenary, lectures, symposia, and interactive sessions interweaving the theme of the annual Congress. Plenary lectures will feature exceptional speakers covering a wide range of themes in reproductive medicine including reproductive rights, recurrent pregnancy loss, early embryo development, ovarian aging, generational aging, menopause, and fertility preservation for pediatric, adolescent and adults as well as restoration for benign and malignant disease. Congress symposia will provide more in-depth coverage of basic and clinical subjects. Topics range from a wide variety of interests including stem cell technology, fertility preservation in adolescents and children with genetic conditions, advance imaging of endometriosis and adenomyosis, barriers to utilization of male fertility care, use of single cell RNA sequencing to probe cell identity, gamete, and embryo donation in 21st century, disparities in addressing uterine fibroids, addressing systemic inequities in reproductive healthcare, primary ovarian insufficiency, automation, artificial intelligence, and Lab on a chip technology. The interactive sessions cover a wide range of stimulating topics and are meant to be a forum for discussion and interaction, including topics such as ovarian insufficiency planning pregnancy: fresh or frozen egg donor, Polycystic Ovary Syndrome, recognizing and referring IVF patient with anxiety, PGT-A and Mosaicism, endometriosis management, genetic of successful FET: ultrasound imaging and PGT-A or Endometrial gene profile, sperm DNA fragmentation in recurrent miscarriages, diversity, equity, and inclusion in reproductive practice, progesterone supplementation in recurrent miscarriages, macroscopic vs. microscopic: uterine factor infertility, human genome editing, fertility preservation advocacy, access and mandates for coverage, ethics, law, and fertility preservation for AYA and transgender patients, uterine septum repair and viable embryo donation options in United States.
Supplementing the CME/CE program will be non-CME/CE events including roundtable luncheons and Expert Encounters that will provide opportunities for in-depth discussion with experts in small-group settings as well as oral and poster scientific abstract presentations that enable investigators to present cutting-edge scientific research in reproductive medicine and biology. Included in the diverse program are “tracks” for specialty and interest areas to enable participants to focus on specific topics and identify areas to expand their knowledge. The 2022 Scientific Congress should provide a chance for learning, improvement of clinical competence, and reproduction for the future of family fertility care.
At the conclusion of the Scientific Congress, participants should be able to: